Immunotoxicity of nivalenol after subchronic dietary exposure to rats

Food and Chemical Toxicology

Volumn 46, Issue 1, 2008, Pages 253-258

  Kubosaki, Atsutaka ^a   Aihara, Maki ^a   Park, Bong Joo ^a   Sugiura, Yoshitsugu ^b   Shibutani, Makoto ^a   Hirose, Masao ^a   Suzuki, Yoshihiko ^c   Takatori, Kosuke ^a   Sugita Konishi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b KOBE INSTITUTE OF HEALTH   (Japan)

^c AZABU UNIVERSITY   (Japan)

Author keywords

F344 rats; Flow cytometry; Immunotoxicity; Natural killer activity; Nivalenol; Subchronic exposure

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NIVALENOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; DIET; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HELPER CELL; IMMUNOTOXICITY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; RAT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CD4-CD8 RATIO; DIET; FEMALE; FLOW CYTOMETRY; FUSARIUM; IMMUNITY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KILLER CELLS, NATURAL; MALE; MYCOTOXINS; RATS; RATS, INBRED F344; SPLEEN; TRICHOTHECENES;

MICRODOCHIUM NIVALE; RATTUS;

EID: 36849062652     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.08.003     Document Type: Article

References (31)

1. Arase K., Saijo K., Watanabe H., Konno A., Arase H., and Saito T. Ablation of a specific cell population by the replacement of a uniquely expressed gene with a toxin gene. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 9264-9268
2. Berek L., Petri I.B., Mesterhazy A., Teren J., and Molnar J. Effects of mycotoxins on human immune functions in vitro. Toxicology in Vitro 15 (2001) 25-30
3. Bony S., Olivier-Loiseau L., Carcelen M., and Devaux A. Genotoxic potential associated with low levels of the Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal cell line. Toxicology in Vitro 21 (2007) 457-465
4. Chambers W.H., Vujanovic N.L., DeLeo A.B., Olszowy M.W., Herberman R.B., and Hiserodt J.C. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. Journal of Experimental Medicine 169 (1989) 1373-1389
5. Choi C.Y., Nakajima-Adachi H., Kaminogawa S., and Sugita-Konishi Y. Nivalenol inhibits total and antigen-specific IgE production in mice. Toxicology and Applied Pharmacology 165 (2000) 94-98
6. Dortant P.M., Peters-Volleberg G.W., Van Loveren H., Marquardt R.R., and Speijers G.J. Age-related differences in the toxicity of ochratoxin A in female rats. Food and Chemical Toxicology 39 (2001) 55-65
7. European Commission, 2000a. Opinion of the Scientific Committee on Food on Fusarium Toxins. Part 4.1.: Nivalenol (NIV), SCF/CS/CNTM/MYC/26 Final. (available at: ).
8. 1), SCF/CS/CNTM/MYC/24 Final. (available at: ).
9. European Commission. 2000c. Opinion of the Scientific Committee on Food on Fusarium Toxins. Part 2.1: Zearalenone (ZEA), SCF/CS/CNTM/MYC/22 Rev 3 Final. (available at: ).
10. Hasui M., Saikawa Y., Miura M., Takano N., Ueno Y., Yachie A., Miyawaki T., and Taniguchi N. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice. Cellular Immunology 120 (1989) 230-239
11. Hedman R., Thuvander A., Gadhasson I., Reverter M., and Pettersson H. Influence of dietary nivalenol exposure on gross pathology and selected immunological parameters in young pigs. Natural Toxins 5 (1997) 238-246
12. Hinoshita F., Suzuki Y., Yokoyama K., Hara S., Yamada A., Ogura Y., Hashimoto H., Tomura S., Marumo F., and Ueno Y. Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol. Nephron 75 (1997) 469-478
13. Hsia C.C., Wu Z.Y., Li Y.S., Zhang F., and Sun Z.T. Nivalenol, a main Fusarium toxin in dietary foods from high-risk areas of cancer of esophagus and gastric cardia in China, induced benign and malignant tumors in mice. Oncology Reports 12 (2004) 449-456
14. Ito Y., Ohtsubo K., Ishii K., and Ueno Y. Effects of nivalenol on pregnancy and fetal development in mice. Mycotoxin Research 2 (1986) 71-77
15. Jansson L., and Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflammation Research 47 (1998) 290-301
16. Kawasaki Y., Uchida O., Sekita K., Matsumoto K., Ochiai T., Usui A., Nakaji Y., Furuta T., Kurokawa Y., and Tobe M. Single and repeated oral administration toxicity studies of nivalenol in F344 rats (Japanese). Shokuhin Eiseigaku Zasshi (Journal of the Food Hygienic Society of Japan) 31 (1990) 144-154
17. Lengi A.J., Phillips R.A., Karpuzoglu E., and Ahmed S.A. Estrogen selectively regulates chemokines in murine splenocytes. Journal of Leukocyte Biology. 81 (2007) 1065-1074
18. Ohtsubo K., Ryu J.C., Nakamura K., Izumiyama N., Tanaka T., Yamamura H., Kobayashi T., and Ueno Y. Chronic toxicity of nivalenol in female mice: a 2-year feeding study with Fusarium nivale Fn 2B-moulded rice. Food and Chemical Toxicology 27 (1989) 591-598
19. + T-cells. Toxicology 104 (1995) 187-202
20. Pestka J.J., Zhou H.R., Moon Y., and Chung Y.J. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicology Letters 153 (2004) 61-73
21. Poapolathep A., Suzuki K., Katayama K., Ohtsuka R., Nagata T., Uetsuka K., Nakayama H., and Doi K. Development of apoptosis and changes in apoptosis-related gene expression in the thymus of nivalenol-treated mice. Journal of Toxicological Pathology 14 (2001) 299-304
22. Poapolathep A., Ohtsuka R., Kiatipattanasakul W., Ishigami N., Nakayama H., and Doi K. Nivalenol-induced apoptosis in thymus, spleen and Peyer's patches of mice. Experimental and Toxicologic Pathology 53 (2002) 441-446
23. Poapolathep A., Nagata T., Suzuki H., Kumagai S., and Doi K. Development of early apoptosis and changes in lymphocyte subsets in lymphoid organs of mice orally inoculated with nivalenol. Experimental and Molecular Pathology 75 (2003) 74-79
24. Poapolathep A., Kumagai S., Suzuki H., and Doi K. Development of early apoptosis and changes in T-cell subsets in mouse thymocyte primary cultures treated with nivalenol. Experimental and Molecular Pathology 77 (2004) 149-152
25. Ryan J.C., Naper C., Hayashi S., and Daws M.R. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunological Reviews 181 (2001) 126-137
26. Ryu J.C., Ohtsubo K., Izumiyama N., Mori M., Tanaka T., and Ueno Y. Effects of nivalenol on the bone marrow in mice. The Journal of Toxicological Sciences 12 (1987) 11-21
27. Ryu J.C., Ohtsubo K., Izumiyama N., Nakamura K., Tanaka T., Yamamura H., and Ueno Y. The acute and chronic toxicities of nivalenol in mice. Fundamental and Applied Toxicology 11 (1988) 38-47
28. Schlatter J. Toxicity data relevant for hazard characterization. Toxicology Letters 153 (2004) 83-89
29. Takahashi M., Shibutani M., Sugita-Konishi Y., Aihara M., Inoue K., Woo G.-H., Fujimoto H., and Hirose M. A 90-day subchronic toxicity study of nivalenol, a trichothecene mycotoxin, in F344 rats. Food and Chemical Toxicology 46 1 (2008) 125-135
30. Yamamura H., Kobayashi T., Ryu J.C., Ueno Y., Nakamura K., Izumiyama N., and Ohtsubo K. Subchronic feeding studies with nivalenol in C57BL/6 mice. Food and Chemical Toxicology 27 (1989) 585-590
31. Zamai L., Ponti C., Mirandola P., Gobbi G., Papa S., Galeotti L., Cocco L., and Vitale M. NK cells and cancer. Journal of Immunology 178 (2007) 4011-4016